Collaboration - November 21, 2025
Mercodia and Attana collaborate
The two companies are entering into a strategic collaboration with the goal of developing next-generation solutions in preclinical drug development.
Collaboration - November 18, 2025
TIRmed Pharma collaborates with Bachem
The collaboration includes process development and manufacturing of TIR-01, the active substance in TIRmed’s treatment for atopic dermatitis (eczema), and marks an important step towards future clinical trials.
Financing - November 17, 2025
Vicore Pharma raises approximately USD 48 million
Vicore Pharma Holding has completed a directed share issue through which the company raises gross proceeds of approximately USD 48 million (approximately SEK 455 million) before deduction of transaction costs.
Acquisition - November 7, 2025
The takeover offer of Bavarian Nordic is withdrawn and will not be completed
Earlier this autumn the company announced a takeover offer to acquire all of the issued and outstanding shares in Bavarian Nordic by Innosera, a company controlled by Nordic Capital Fund XI and funds managed and advised by Permira Beteiligungsberatung. The offeror has now informed Bavarian Nordic that, as the minimum acceptance condition has not been satisfied, […]
New Market - November 5, 2025
Moberg Pharma and Karo Healthcare in license agreement
Moberg Pharma has entered into an exclusive licensing agreement with Karo Healthcare regarding the commercialization of MOB-015 (Terclara) in Europe.
Collaboration - October 27, 2025
Lundbeck in strategic collaboration with OpenAI
Through the deployment of ChatGPT Enterprise to its global workforce, Lundbeck will empower employees with AI capabilities designed to accelerate discovery, enhance decision-making, and drive unprecedented efficiency, it states.
